The HALO is a new lifesaving test that every woman needs to know about.
Mammography is recommended for breast cancer screening by age 40, but Halo offers an alternative to younger women for detecting early signs of breast cancer.
The HALO breast pap test is a new breast cancer risk assessment test developed by NeoMatrix.
HALO is FDA-cleared for the collection of nipple aspirate fluid for cytological evaluation.
Dr. Walker explains the new recommended screening rules for mammograms and four main strategies for early breast cancer detection.
The Halo test is a new breast cancer screening technology that could save your life.
The HALO Test is a new screening process to assess a woman's risk for developing breast cancer.
The HALO Test is a new way to discover breast cancer risk. This screening test is for women 25 and older and takes only 5 minutes.
The HALO Pap Test for the Breast is an early screening process for younger women.
The HALO Breast Pap Test offers a possible breakthrough in the fight against breast cancer.
HALO is a 5 minute completely noninvasive breast cancer risk assessment test that can tell women if they are at high risk for eventually developing breast cancer.
This 5 minute test determines whether or not there are abnormal cells in the breast ducts. HALO is recommended for women age 25 and older as part of their annual exam.
The HALO test offers the opportunity for the prevention of breast cancer by finding early warning signs years before a tumor might develop.
HALO can help to screen for first signs of breast cancer risk 8 years before cancer might be detected with a mammogram.
The FDA-approved HALO Breast Pap Test is a simple, five-minute test that identifies early warning signs of breast cancer.
The HALO Breast Pap Test by NeoMatrix collects nipple fluid that is then checked for abnormal cells, which can indicate higher risk of breast cancer.
Breast cancer research has discovered a new method to screen for breast cancer.
Studies have shown that a mammogram is less likely to detect breast cancer in young women.
The HALO Breast Pap Test is a new test that can help to detect breast disease in its early stages.
The HALO test is a new FDA-cleared breast cancer screening test that supports women in the fight against breast cancer.
Early detection is key in fighting breast cancer. The new HALO exam uses a device that aspirates fluid from the nipple.
Information on clinical breast cancer FAQs to help you understand the signs and symptoms of breast cancer and precautions you should be taking.
NeoMatrix provides breast cancer information and also offers a new state of the art technology that can detect cellular changes years before a lump can be detected with mammography.
The goal of breast cancer risk assessment is to find high risk women before they develop cancer.
New screening test helps to detect breast cancer risk factors
Latest Comments